LAS VEGAS, Nevada, June 28, 2017 -- Praxsyn Corporation (OTCQB: PXYN) is pleased to announce that the board of directors of Nevada Health Rx, Inc. (“NHRX”) has appointed Scot Silber as its President and managing pharmacist.
Mr. Silber, has been a registered pharmacist for over 35 years, and brings over 40 years of pharmacy and business management expertise to the company. Mr. Silber enlisted in the U.S. Army in 1973, and served for 4 years as a pharmacy technician. This experience motivated Mr. Silber to continue his pharmacy education by attending the University of Wyoming, School of Pharmacy. After graduating in 1982, Mr. Silber moved to Las Vegas, NV and initially worked in a Hospital Pharmacy. Thereafter, he entered into the world of independent pharmacy with the purchase of Red Rock Medical Pharmacy. In 1986, he expanded into home infusion therapy as part owner of Nevada’s largest home infusion company, TPN of Las Vegas. In 1991, he left TPN to open a new venture – VED Ancillary Service, a full service home infusion/medical supply company. In February 1995, Mr. Silber merged VED Ancillary Services into Rainbow Medical, a company formed to expand medical services to managed care organizations and physicians’ offices. In May of 2001, Mr. Silber established FVS Holdings, LLC as the parent company for Green Valley Drugs, Green Valley Medical Supply, and Green Valley Dental Supply. In 2003, he sold his retail pharmacy, Green Valley Drugs, to a large grocery store chain to focus his efforts on FVS Holdings, LLC. In 2010, Mr. Silber sold Green Valley Medical Supply to a large publicly traded medical supply company. After divesting his interests in FVS Holdings, LLC, Mr. Silber joined Partell Specialty Pharmacy as the Vice President of Pharmacy Operations.
Mr. Silber’s lifelong dedication to charitable organizations is exemplified by his many achievements including being awarded the “Bowl of Hygenia” Community Service Award 2002, for the State of Nevada. In his free time, Mr. Silber devotes much of his time serving as the Chairman of the Board for the Nevada Childhood Cancer Foundation.
Praxsyn’s Chief Executive Officer, Greg Sundem, commented, “We are pleased to add Mr. Silber to our management team with his many years of business and pharmacy experience. We look forward to the company’s overall expansion on a national level in the future with Mr. Silber driving the pharmacy division”.
About Praxsyn Corporation
Headquartered in Las Vegas, Nevada, Praxsyn Corporation through its wholly owned subsidiaries Mesa Pharmacy and Nevada Health Rx, work to realize the vision of medical professionals to improve the lives of their patients. Additional company information can be found at www.praxsyn.com.
Forward-Looking Statements
Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) including but not limited to statements in this press release regarding the appointment of Mr. Silber as President of Nevada Health Rx, Inc., and thus accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports as have been filed with the Securities and Exchange Commission.
Media/Investor Contact: [email protected] 949-777-6112 ext. 101


DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Washington Post Publisher Will Lewis Steps Down After Layoffs
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 



